A gene engineered subunit vaccine or a bio-recombinant subunit vaccine refers to the expression of a protective antigen gene in a prokaryotic or eukaryotic cell, and a vaccine made from a gene product?protein or polypeptide.
This report aims to provide a comprehensive presentation of the global market for Gene Engineered Subunit Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gene Engineered Subunit Vaccine. This report contains market size and forecasts of Gene Engineered Subunit Vaccine in global, including the following market information:
Global Gene Engineered Subunit Vaccine Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Gene Engineered Subunit Vaccine market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Therapeutic Gene Engineered Subunit Vaccine Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Gene Engineered Subunit Vaccine include Merck, GSK, Tiantan, Pulike, Greffex, CureVac, Yebio, Sanofi Pasteur SA and Virbac, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Gene Engineered Subunit Vaccine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Gene Engineered Subunit Vaccine Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Gene Engineered Subunit Vaccine Market Segment Percentages, by Type, 2022 (%)
Therapeutic Gene Engineered Subunit Vaccine
Preventative Gene Engineered Subunit Vaccine
Global Gene Engineered Subunit Vaccine Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Gene Engineered Subunit Vaccine Market Segment Percentages, by Application, 2022 (%)
Human Use
Veterinary Use
Global Gene Engineered Subunit Vaccine Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Gene Engineered Subunit Vaccine Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Gene Engineered Subunit Vaccine revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Gene Engineered Subunit Vaccine revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Merck
GSK
Tiantan
Pulike
Greffex
CureVac
Yebio
Sanofi Pasteur SA
Virbac
Pfizer Inc.
Walvax Biotechnology
Kontec
Outline of Major Chapters:
Chapter 1: Introduces the definition of Gene Engineered Subunit Vaccine, market overview.
Chapter 2: Global Gene Engineered Subunit Vaccine market size in revenue.
Chapter 3: Detailed analysis of Gene Engineered Subunit Vaccine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Gene Engineered Subunit Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Gene Engineered Subunit Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Gene Engineered Subunit Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Gene Engineered Subunit Vaccine Overall Market Size
2.1 Global Gene Engineered Subunit Vaccine Market Size: 2022 VS 2029
2.2 Global Gene Engineered Subunit Vaccine Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Gene Engineered Subunit Vaccine Players in Global Market
3.2 Top Global Gene Engineered Subunit Vaccine Companies Ranked by Revenue
3.3 Global Gene Engineered Subunit Vaccine Revenue by Companies
3.4 Top 3 and Top 5 Gene Engineered Subunit Vaccine Companies in Global Market, by Revenue in 2022
3.5 Global Companies Gene Engineered Subunit Vaccine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Players in Global Market
3.6.1 List of Global Tier 1 Gene Engineered Subunit Vaccine Companies
3.6.2 List of Global Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Gene Engineered Subunit Vaccine Market Size Markets, 2022 & 2029
4.1.2 Therapeutic Gene Engineered Subunit Vaccine
4.1.3 Preventative Gene Engineered Subunit Vaccine
4.2 By Type - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
4.2.1 By Type - Global Gene Engineered Subunit Vaccine Revenue, 2018-2023
4.2.2 By Type - Global Gene Engineered Subunit Vaccine Revenue, 2024-2029
4.2.3 By Type - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Gene Engineered Subunit Vaccine Market Size, 2022 & 2029
5.1.2 Human Use
5.1.3 Veterinary Use
5.2 By Application - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
5.2.1 By Application - Global Gene Engineered Subunit Vaccine Revenue, 2018-2023
5.2.2 By Application - Global Gene Engineered Subunit Vaccine Revenue, 2024-2029
5.2.3 By Application - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Gene Engineered Subunit Vaccine Market Size, 2022 & 2029
6.2 By Region - Global Gene Engineered Subunit Vaccine Revenue & Forecasts
6.2.1 By Region - Global Gene Engineered Subunit Vaccine Revenue, 2018-2023
6.2.2 By Region - Global Gene Engineered Subunit Vaccine Revenue, 2024-2029
6.2.3 By Region - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Gene Engineered Subunit Vaccine Revenue, 2018-2029
6.3.2 US Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.3.3 Canada Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.3.4 Mexico Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Gene Engineered Subunit Vaccine Revenue, 2018-2029
6.4.2 Germany Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4.3 France Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4.4 U.K. Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4.5 Italy Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4.6 Russia Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4.7 Nordic Countries Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.4.8 Benelux Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Gene Engineered Subunit Vaccine Revenue, 2018-2029
6.5.2 China Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.5.3 Japan Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.5.4 South Korea Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.5.5 Southeast Asia Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.5.6 India Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Gene Engineered Subunit Vaccine Revenue, 2018-2029
6.6.2 Brazil Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.6.3 Argentina Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, 2018-2029
6.7.2 Turkey Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.7.3 Israel Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.7.4 Saudi Arabia Gene Engineered Subunit Vaccine Market Size, 2018-2029
6.7.5 UAE Gene Engineered Subunit Vaccine Market Size, 2018-2029
7 Gene Engineered Subunit Vaccine Companies Profiles
7.1 Merck
7.1.1 Merck Company Summary
7.1.2 Merck Business Overview
7.1.3 Merck Gene Engineered Subunit Vaccine Major Product Offerings
7.1.4 Merck Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.1.5 Merck Key News & Latest Developments
7.2 GSK
7.2.1 GSK Company Summary
7.2.2 GSK Business Overview
7.2.3 GSK Gene Engineered Subunit Vaccine Major Product Offerings
7.2.4 GSK Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.2.5 GSK Key News & Latest Developments
7.3 Tiantan
7.3.1 Tiantan Company Summary
7.3.2 Tiantan Business Overview
7.3.3 Tiantan Gene Engineered Subunit Vaccine Major Product Offerings
7.3.4 Tiantan Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.3.5 Tiantan Key News & Latest Developments
7.4 Pulike
7.4.1 Pulike Company Summary
7.4.2 Pulike Business Overview
7.4.3 Pulike Gene Engineered Subunit Vaccine Major Product Offerings
7.4.4 Pulike Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.4.5 Pulike Key News & Latest Developments
7.5 Greffex
7.5.1 Greffex Company Summary
7.5.2 Greffex Business Overview
7.5.3 Greffex Gene Engineered Subunit Vaccine Major Product Offerings
7.5.4 Greffex Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.5.5 Greffex Key News & Latest Developments
7.6 CureVac
7.6.1 CureVac Company Summary
7.6.2 CureVac Business Overview
7.6.3 CureVac Gene Engineered Subunit Vaccine Major Product Offerings
7.6.4 CureVac Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.6.5 CureVac Key News & Latest Developments
7.7 Yebio
7.7.1 Yebio Company Summary
7.7.2 Yebio Business Overview
7.7.3 Yebio Gene Engineered Subunit Vaccine Major Product Offerings
7.7.4 Yebio Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.7.5 Yebio Key News & Latest Developments
7.8 Sanofi Pasteur SA
7.8.1 Sanofi Pasteur SA Company Summary
7.8.2 Sanofi Pasteur SA Business Overview
7.8.3 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Major Product Offerings
7.8.4 Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.8.5 Sanofi Pasteur SA Key News & Latest Developments
7.9 Virbac
7.9.1 Virbac Company Summary
7.9.2 Virbac Business Overview
7.9.3 Virbac Gene Engineered Subunit Vaccine Major Product Offerings
7.9.4 Virbac Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.9.5 Virbac Key News & Latest Developments
7.10 Pfizer Inc.
7.10.1 Pfizer Inc. Company Summary
7.10.2 Pfizer Inc. Business Overview
7.10.3 Pfizer Inc. Gene Engineered Subunit Vaccine Major Product Offerings
7.10.4 Pfizer Inc. Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.10.5 Pfizer Inc. Key News & Latest Developments
7.11 Walvax Biotechnology
7.11.1 Walvax Biotechnology Company Summary
7.11.2 Walvax Biotechnology Business Overview
7.11.3 Walvax Biotechnology Gene Engineered Subunit Vaccine Major Product Offerings
7.11.4 Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.11.5 Walvax Biotechnology Key News & Latest Developments
7.12 Kontec
7.12.1 Kontec Company Summary
7.12.2 Kontec Business Overview
7.12.3 Kontec Gene Engineered Subunit Vaccine Major Product Offerings
7.12.4 Kontec Gene Engineered Subunit Vaccine Revenue in Global Market (2018-2023)
7.12.5 Kontec Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Gene Engineered Subunit Vaccine Market Opportunities & Trends in Global Market
Table 2. Gene Engineered Subunit Vaccine Market Drivers in Global Market
Table 3. Gene Engineered Subunit Vaccine Market Restraints in Global Market
Table 4. Key Players of Gene Engineered Subunit Vaccine in Global Market
Table 5. Top Gene Engineered Subunit Vaccine Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Gene Engineered Subunit Vaccine Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Gene Engineered Subunit Vaccine Revenue Share by Companies, 2018-2023
Table 8. Global Companies Gene Engineered Subunit Vaccine Product Type
Table 9. List of Global Tier 1 Gene Engineered Subunit Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Gene Engineered Subunit Vaccine Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Gene Engineered Subunit Vaccine Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Gene Engineered Subunit Vaccine Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Gene Engineered Subunit Vaccine Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2024-2029
Table 30. Merck Company Summary
Table 31. Merck Gene Engineered Subunit Vaccine Product Offerings
Table 32. Merck Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 33. Merck Key News & Latest Developments
Table 34. GSK Company Summary
Table 35. GSK Gene Engineered Subunit Vaccine Product Offerings
Table 36. GSK Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 37. GSK Key News & Latest Developments
Table 38. Tiantan Company Summary
Table 39. Tiantan Gene Engineered Subunit Vaccine Product Offerings
Table 40. Tiantan Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 41. Tiantan Key News & Latest Developments
Table 42. Pulike Company Summary
Table 43. Pulike Gene Engineered Subunit Vaccine Product Offerings
Table 44. Pulike Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 45. Pulike Key News & Latest Developments
Table 46. Greffex Company Summary
Table 47. Greffex Gene Engineered Subunit Vaccine Product Offerings
Table 48. Greffex Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 49. Greffex Key News & Latest Developments
Table 50. CureVac Company Summary
Table 51. CureVac Gene Engineered Subunit Vaccine Product Offerings
Table 52. CureVac Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 53. CureVac Key News & Latest Developments
Table 54. Yebio Company Summary
Table 55. Yebio Gene Engineered Subunit Vaccine Product Offerings
Table 56. Yebio Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 57. Yebio Key News & Latest Developments
Table 58. Sanofi Pasteur SA Company Summary
Table 59. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Product Offerings
Table 60. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 61. Sanofi Pasteur SA Key News & Latest Developments
Table 62. Virbac Company Summary
Table 63. Virbac Gene Engineered Subunit Vaccine Product Offerings
Table 64. Virbac Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 65. Virbac Key News & Latest Developments
Table 66. Pfizer Inc. Company Summary
Table 67. Pfizer Inc. Gene Engineered Subunit Vaccine Product Offerings
Table 68. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 69. Pfizer Inc. Key News & Latest Developments
Table 70. Walvax Biotechnology Company Summary
Table 71. Walvax Biotechnology Gene Engineered Subunit Vaccine Product Offerings
Table 72. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 73. Walvax Biotechnology Key News & Latest Developments
Table 74. Kontec Company Summary
Table 75. Kontec Gene Engineered Subunit Vaccine Product Offerings
Table 76. Kontec Gene Engineered Subunit Vaccine Revenue (US$, Mn) & (2018-2023)
Table 77. Kontec Key News & Latest Developments
List of Figures
Figure 1. Gene Engineered Subunit Vaccine Segment by Type in 2022
Figure 2. Gene Engineered Subunit Vaccine Segment by Application in 2022
Figure 3. Global Gene Engineered Subunit Vaccine Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Gene Engineered Subunit Vaccine Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Gene Engineered Subunit Vaccine Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Gene Engineered Subunit Vaccine Revenue in 2022
Figure 8. By Type - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 9. By Application - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 10. By Type - Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 12. By Application - Global Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 14. By Region - Global Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 15. By Country - North America Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 16. US Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 20. Germany Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 21. France Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 28. China Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 32. India Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 34. Brazil Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Gene Engineered Subunit Vaccine Revenue Market Share, 2018-2029
Figure 37. Turkey Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Gene Engineered Subunit Vaccine Revenue, (US$, Mn), 2018-2029
Figure 41. Merck Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. GSK Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Tiantan Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pulike Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Greffex Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. CureVac Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Yebio Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Sanofi Pasteur SA Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Virbac Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Pfizer Inc. Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Walvax Biotechnology Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Kontec Gene Engineered Subunit Vaccine Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
